The key to successful investing lies in choosing the right stocks. However, this is no easy task.
Investors use a wide range of strategies to pick stocks: some trust their instincts, others analyze past performance, and many lean on expert advice. For those seeking a more unbiased, data-driven approach, TipRanks’ Smart Score offers an ideal solution. This advanced algorithm uses AI and natural language processing to sift through vast amounts of data from public trading floors, providing a clear and objective guide for investors.
That data is a treasure trove of stock information, based on the aggregated trades of thousands of investors in thousands of stocks, with tens of millions of trades per day. It would take a lifetime to sort through and understand it, but Smart Score automates that, using the data to give each stock a simple rating, on a scale of 1 to 10, based on a group of factors proven to correlate with future outperformance. A stock with a “Perfect 10” score deserves a closer look and deeper consideration.
When the Smart Score aligns with the recommendations of Wall Street analysts, it signals a strong, bullish opportunity for investors. With this in mind, we used the TipRanks platform to investigate what analysts think of two of the highest-scoring “Perfect 10” stocks. Here’s a closer look at these stocks and the analyst insights.
PowerFleet (AIOT)
We start with PowerFleet, a company specializing in combining AI and IoT technology into a unified platform that integrates people, assets, and AIoT data for optimized operations. In practical terms, the company’s platform enables enterprise customers to effectively manage industrial fleets—trucks, tractors, intermodal shipping containers, and other vehicles—ensuring security, tracking, and overall control of these valuable assets.
PowerFleet’s customer-facing capabilities include regulatory management and compliance, safety and security, fuel management, and maintenance and performance monitoring – all essential activities to keep industrial fleets running at peak performance. The company has more than 7,500 customers worldwide and offers world-class support, educational and implementation services on demand.
In its latest earnings report for fiscal Q1 2025, which ended June 30, PowerFleet posted revenue of $75.4 million, reflecting a year-over-year increase of ~10%. Of this total, $56.7 million was generated by the company’s Services segment, with “safety-focused product solutions” contributing significantly to revenue growth. On the earnings front, the company’s non-GAAP EPS came in at $0.00, shy of breakeven.
According to Anthony Stoss, analyst at Craig-Hallum, PowerFleet stands out as a high-quality technology company with a lot of potential.
“We continue to believe investors should own AIOT as we see them developing into a strong SaaS player with an interoperable software platform across 130 different third-party devices. We note that the company continues to see strength around security applications with safety solutions up 25% y/y. We also highlight that AIOT grew their total subscriber base 11% y/y to 1.95 million and management sees acceleration with their Unity platform,” Stoss said.
Looking ahead, Stoss outlines a clear path for PowerFleet to maintain its solid performance, adding: “We continue to reiterate our view of a ‘one plus one equals three’ scenario unfolding across the enterprise from in-warehouse to in-the-field solutions. We continue to believe investors will find value in AIOT with strong long-term growth prospects, more than 7,500 enterprise customers globally, an ARPU of over $20 and now with 75% of revenue recurring.”
These comments confirm the 5-star analyst’s Buy rating on AIOT shares, while his $9 price target implies an 80% annualized gain. (Click here to watch Stoss’ track record)
Overall, AIOT has earned a Strong Buy consensus rating from the Street, based on 6 unanimously positive analyst reviews. Shares are priced just under $5, and their $9 average price target is in line with the Craig-Hallum view. (See AIOT Stock Analysis)
AngioDynamics (ANGO)
The next stock we’re going to look at, AngioDynamics, is a medical device developer and innovator that has been in the medtech space since 1988. The company has a strong portfolio of medical devices and products designed to give physicians the tools they need to provide a higher standard of care to patients with cardiovascular and oncologic diseases. These two medical categories are the leading causes of death worldwide. Cancer accounts for 1 in 6 deaths worldwide; AngioDynamics aims to reduce that number.
AngioDynamics works toward that goal by offering medical devices that target multiple medical specialties, including interventional radiology, interventional cardiology, and surgery. The devices are used to diagnose various types of cancer and peripheral vascular disease and are designed to minimize invasive surgery.
Several products from AngioDynamics deserve special attention. These include the AlphaVac, a therapeutic device used in endovascular procedures; the NanoKnife, which can provide localized treatments for various types of cancer; and the Auryon, another endovascular treatment device optimized for peripheral atherectomy technology. These and many other high-quality medical devices are available in more than 50 markets worldwide, in the U.S., Europe, Asia and Latin America.
In its most recent fiscal 4Q24 report, for the quarter ended May 31, AngioDynamics beat expectations on both the top and bottom lines. The company reported revenue of $70.98 million, down 22% year-over-year, but still managed to beat estimates by $120,000. On the bottom line, AngioDynamics posted a net loss of 5 cents per share — while negative, this was a significant 23 cents per share better than expected.
For Canaccord Genuity analyst John Young, it all adds up to a healthy outlook for the company. He says of the medical device maker’s prospects: “AngioDynamics remains focused on 1) pursuing larger, faster-growing markets, 2) driving portfolio transformation, and 3) improving its financial profile and capital structure. Q4 results show that this strategy is starting to pay off… Looking ahead, we believe ANGO is on solid footing with momentum and catalysts in the Med-Tech business across the board — AlphaVac, NanoKnife and Auryon present opportunities that make us cautiously optimistic, particularly given ANGO’s current valuation.”
Young goes on to give ANGO shares a Buy rating and adds a $13 price target, signaling his confidence in 74% upside potential over the one-year horizon. (Click here to watch Young’s track record)
Overall, there are 3 recent analyst ratings on file for ANGO stock and they all agree that this is a stock to buy, making the Strong Buy consensus rating unanimous. The stock is trading at $7.46 and the average price target, at $13.33, is slightly more bullish than the Canaccord view, indicating room for ~79% appreciation in the coming months. (See ANGO Stock Analysis)
To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a tool that unites all of TipRanks’ equity insights.
Disclaimer: The opinions expressed in this article are solely those of the analysts mentioned. The content is for informational purposes only. It is very important to do your own analysis before making any investment.
